Spots Global Cancer Trial Database for lip and oral cavity squamous cell carcinoma

Every month we try and update this database with for lip and oral cavity squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental Care	NCT01816841	Lip and Oral Ca... Oral Cavity Ver... Stage 0 Lip and... Tongue Cancer	fluorescence im... biopsy examination Comparison of s...	18 Years -	Ohio State University Comprehensive Cancer Center
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer	NCT00003139	Head and Neck C... Oral Complicati...	pilocarpine hyd... Placebo	18 Years - 120 Years	Radiation Therapy Oncology Group
Validation of a Screening Tool in Geriatric Oncology	NCT00963911	Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Lymphoma Prostate Cancer	Geriatric scree... Multidimensiona...	70 Years - 120 Years	Institut Bergonié
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study	NCT05136196	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Lip and Oral Ca... Melanoma Oropharyngeal S... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha...	Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery	NCT02734537	Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Laryngeal Squam... Lip and Oral Ca... p16INK4a Negati... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oral ... Stage III Oroph... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Lip a... Stage IVA Oral ... Stage IVA Oroph...	Cisplatin Intensity-Modul... Laboratory Biom...	18 Years -	Eastern Cooperative Oncology Group
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study	NCT05136196	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Lip and Oral Ca... Melanoma Oropharyngeal S... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha...	Biopsy Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab	18 Years -	National Cancer Institute (NCI)
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer	NCT00003139	Head and Neck C... Oral Complicati...	pilocarpine hyd... Placebo	18 Years - 120 Years	Radiation Therapy Oncology Group
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery	NCT02734537	Head and Neck S... Hypopharyngeal ... Laryngeal Squam... Laryngeal Squam... Lip and Oral Ca... p16INK4a Negati... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oral ... Stage III Oroph... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Lip a... Stage IVA Oral ... Stage IVA Oroph...	Cisplatin Intensity-Modul... Laboratory Biom...	18 Years -	Eastern Cooperative Oncology Group
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions	NCT01414426	Lip and Oral Ca... Oral Cavity Ver... Precancerous Co...	vandetanib placebo immunohistochem... laboratory biom... biopsy pharmacological...	18 Years -	University of Chicago

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: